hotspot -WSS

hotspot

author：focus 2025-10-01 14:38:03 - browse：781

Illustration of several road hurdles leading to a microscope — Molly Ferguson for STAT

Scientists at the University of Wisconsin-Madison have spent years trying to unravel the details of Down syndrome: What happens inside the womb, how the genetic disorder alters the formation of neurons, and what specific processes affect brain development. The work can’t proceed without studying fetal tissue.

Anita Bhattacharyya, an associate professor of cell and regenerative biology, said her lab’s findings so far are significant, having identified a layer of late-developing neurons that are reduced in the brains of fetuses with Down syndrome. If she were to start her career again, however, she isn’t sure she would follow the same path. “It seems too risky,” she said. She warily monitors the state legislature, where there is ongoing debate, and therefore uncertainty, over changes to rules governing fetal tissue research. And much is riding on the outcome of the November presidential election.

Fetal tissue is used for a broad swath of biological and medical studies, including work with stem cells and research on cancer biology and brain development. The Trump administration created significant barriers to this research and, though they were lifted after President Biden’s election, federal funding of studies relying on fetal tissue has not fully rebounded.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Akero's treatment for NASH falls short in cirrhosis study

WSS

Fatty liver disease was alleviated by Lilly’s ‘triple

A fraught question for the kids of Alzheimer’s: Is it coming for us?

European regulators recommend Amylyx's ALS drug be rejected

Takeaways from AdvaMed, the largest medical devices conference

'Screen and refer' systems are hurting patients

STAT Readout: Today's biotech news includes Sana and Amylyx

leisure time

hotspot

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Peter Marks talks Operation Warp Speed for Rare Diseases

What does generative AI mean for health care? We asked experts

Akero's treatment for NASH falls short in cirrhosis study

After affirmative action ruling, medical educators look to 'holistic review'

Medicare to cover more brain scans related to Alzheimer’s drugs

Affirmative action in medical school literally saved lives

STAT Readout: Today's biotech news includes Sana and Amylyx

DIEP, the 'gold standard' of breast reconstruction, is under threat

Nick Jonas talks about managing diabetes along with his career

Wikipedia

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Skip the lead apron during X

A revolution in caring for preterm infants

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Hubble vs. James Webb telescope images: See the difference

AstraZeneca lung cancer study comes in below expectations

knowledge

hotspot

focus

entertainment